Ownership

John Furey

Insider Reports History

Entity: Individual
Location: 3737 Market Street, Suite 1300, Philadelphia, PA
Signature: John Furey, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions: Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by John Furey:

Stock	Role	Class	Num Shares	Value	Price $	Report Date	Ownership
Adaptimmune Therapeutics PLC	Director	Option to purchase Ordinary Shares	660K			Jul 1, 2024	Direct
Vaxcyte, Inc.	Director	Stock Option (right to buy)	16.8K			Jul 2, 2024	Direct
Vaxcyte, Inc.	Director	No securities owned.	0			Jul 2, 2024	Direct

Showing 1 to 3 of 3 entries

Insider Reports Filed by John Furey

Symbol	Company	Period	Transactions	Value $	Form Type	Date Filed	Role
PCVX	Vaxcyte, Inc.	Jul 2, 2024	1	$0	4	Jul 3, 2024	Director
PCVX	Vaxcyte, Inc.	Jul 2, 2024	0	$0	3	Jul 3, 2024	Director
ADAP	Adaptimmune Therapeutics PLC	Jul 1, 2024	1	$0	4	Jul 1, 2024	Director
ADAP	Adaptimmune Therapeutics PLC	Jul 3, 2023	1	$0	4	Jul 3, 2023	Director
ADAP	Adaptimmune Therapeutics PLC	Jul 1, 2022	1	$0	4	Jul 1, 2022	Director
ADAP	Adaptimmune Therapeutics PLC	Jul 1, 2021	1	$0	4	Jul 2, 2021	Director